Quartet Medicine adds Henry Skinner to its Board after raising $17M in Series A financing round led by Atlas Venture
– USA, MA – Quartet Medicine, a biotechnology company focused on the development of novel treatments for chronic pain and inflammation, today announced the company raised $17 million in a Series A financing.…